ALC:NYSE
Alcon AG
$65.92
arrow_downward
-0.39%(-0.26) 1D
Oct 19, 11:29:22 AM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ALC...
Open
$65.50
High
$65.94
Low
$65.44
Mkt. cap
27.06B
Avg. vol.
1.80M
Volume
282.14K
52-wk high
$87.64
52-wk low
$61.84
Beta
0.88
Shares outstanding
483.40M
No. of employees
25K
Open
$65.50
High
$65.94
Low
$65.44
Mkt. cap
27.06B
Avg. vol.
1.80M
Volume
282.14K
52-wk high
$87.64
52-wk low
$61.84
Beta
0.88
Shares outstanding
483.40M
No. of employees
25K
News stories
From web sources and news partners
ad-hoc-news.de
·
22 minutes ago
Alcon stock: BTIG cuts target for Alcon stock from USD 82.00 to USD 74.00
ad-hoc-news.de
·
7 hours ago
Alcon announces BRYTLY approval: Mizuho cuts target for Alcon stock
ad-hoc-news.de
·
23 hours ago
Alcon announces BRYTLY approval as Alcon stock trades at EUR 58.83
ad-hoc-news.de
·
2 days ago
Alcon announces BRYTLY approval as Alcon stock enters review
Profile
Alcon Inc. is a Swiss-American pharmaceutical and medical device company specializing in eye care products. Alcon is incorporated in the Canton of Fribourg, Switzerland, and its global headquarters are located in Geneva, but its main operational base is in Fort Worth, Texas, United States, where it employs about 4,500 people.
Alcon was a subsidiary of Novartis until April 2019, when it was spun out into a separate publicly traded company. Alcon itself has a number of subsidiaries, including Aerie Pharmaceuticals, focused on therapies for glaucoma and other diseases of the eye, and WaveLight, which develops and manufactures laser eye surgery technologies. Wikipedia
About Alcon AG
CEODavid J. Endicott
Employees25K
Founded1945
HeadquartersGeneva, Geneva, Switzerland
SectorMedical device
Websitealcon.com